Arix Bioscience PLC (ARIX) Unaudited NAV for November 2022 12-Dec-2022 / 07:00 GMT/BST Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement.

-----------------------------------------------------------------------------------------------------------------------

Arix Bioscience plc

Unaudited NAV for November 2022

LONDON, 12 December 2022: Arix Bioscience plc ("Arix" or the "Company") (LSE: ARIX), a global venture capital company focused on investing in breakthrough biotechnology companies, announces the unaudited Net Asset Value ("NAV") of the Company for the date ended 30 November 2022 as follows:

               NAV Breakdown 
Date                                                                       Total NAV 
               Listed Portfolio Unlisted Portfolio Cash    Other Interests           NAV per share 
30 November 22 
               GBP41.8m           GBP57.1m             GBP130.0m GBP1.9m           GBP230.8m   GBP1.79 
(unaudited)

[ENDS]

Enquiries

For more information on Arix, please contact:

Arix Bioscience plc

+44 (0)20 7290 1050

ir@arixbioscience.com

Powerscourt Group

Sarah MacLeod, Ibrahim Khalil, Nick Johnson

+44 (0)20 7250 1446

arix@powerscourt-group.com

About Arix Bioscience plc

Arix Bioscience plc is a global venture capital company focused on investing in breakthrough biotechnology companies around cutting-edge advances in life sciences.

We collaborate with exceptional entrepreneurs and provide the capital, expertise, and global networks to help accelerate their ideas into important new treatments for patients. As a listed company, we are able to bring this exciting growth phase of our industry to a broader range of investors. www.arixbioscience.com

-----------------------------------------------------------------------------------------------------------------------

ISIN:          GB00BD045071 
Category Code: NAV 
TIDM:          ARIX 
LEI Code:      213800OVT3AHQCXNIX43 
Sequence No.:  207309 
EQS News ID:   1508581 
 
End of Announcement  EQS News Service 
=------------------------------------------------------------------------------------

Image link: https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=1508581&application_name=news

(END) Dow Jones Newswires

December 12, 2022 02:00 ET (07:00 GMT)

Arix Bioscience (LSE:ARIX)
Gráfico Histórico do Ativo
De Dez 2024 até Jan 2025 Click aqui para mais gráficos Arix Bioscience.
Arix Bioscience (LSE:ARIX)
Gráfico Histórico do Ativo
De Jan 2024 até Jan 2025 Click aqui para mais gráficos Arix Bioscience.